Involvement of Brca1 in S-Phase and G₂-Phase Checkpoints after Ionizing Irradiation

REFERENCES

• Beamish, H., R. Williams, P. Chen, and M. F. Lavin. 1996. Defect in multiple cell cycle checkpoints in ataxia-telangiectasia postirradiation. J. Biol. Chem. 271:20486–20493.
   PubMed Web of Science ®Google Scholar
• Canman, C. E., D. S. Lim, K. A. Cimprich, Y. Taya, K. Tamai, K. Sakaguchi, E. Appella, M. B. Kastan, and J. D. Siliciano. 1998. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281:1677–1679.
   PubMed Web of Science ®Google Scholar
• Canman, C. E., A. C. Wolff, C. Y. Chen, A. J. Fornace Jr., and M. B. Kastan. 1994. The p53-dependent G1 cell cycle checkpoint pathway and ataxia-telangiectasia. Cancer Res. 54:5054–5058.
   PubMed Web of Science ®Google Scholar
• Carney, J. P., R. S. Maser, H. Olivares, E. M. Davis, M. Le Beau, J. R. Yates III, L. Hays, W. F. Morgan, and J. H. Petrini. 1998. The hMre11/hRad50 protein complex and Nijmegen breakage syndrome: linkage of double-strand break repair to the cellular DNA damage response. Cell 93:477–486.
   PubMed Web of Science ®Google Scholar
• Cortez, D., Y. Wang, J. Qin, and S. J. Elledge. 1999. Requirement of ATM-dependent phosphorylation of Brca1 in the DNA damage response to double-strand breaks. Science 286:1162–1166.
   PubMed Web of Science ®Google Scholar
• Elledge, S. J.. 1996. Cell cycle checkpoints: preventing an identity crisis. Science 274:1664–1672.
   PubMed Web of Science ®Google Scholar
• Hartwell, L. H., and M. B. Kastan. 1994. Cell cycle control and cancer. Science 266:1821–1828.
   PubMed Web of Science ®Google Scholar
• Juan, G., F. Traganos, W. James, J. Ray, M. Roberge, D. Sauve, H. Anderson, and Z. Darzynkiewicz. 1998. Histone H3 phosphorylation and expression of cyclins A and B1 measured in individual cells during their progression through G2 and mitosis. Cytometry 32:71–77.
   PubMedGoogle Scholar
• Kastan, M. B., Q. Zhan, W. S. el-Deiry, F. Carrier, T. Jacks, W. V. Walsh, B. S. Plunkett, B. Vogelstein, and A. J. Fornace Jr.. 1992. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71:587–597.
   PubMed Web of Science ®Google Scholar
• Khosravi, R., R. Maya, T. Gottlieb, M. Oren, Y. Shiloh, and D. Shkedy. 1999. Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage. Proc. Natl. Acad. Sci. USA 96:14973–14977.
   PubMed Web of Science ®Google Scholar
• Lavin, M. F., and Y. Shiloh. 1997. The genetic defect in ataxia-telangiectasia. Annu. Rev. Immunol. 15:177–202.
   PubMed Web of Science ®Google Scholar
• Li, S., N. Y. Y. Ting, L. Zheng, P.-L. Chen, Y. Ziv, Y. Shiloh, E. Y.-H. Lee, and W.-H. Lee. 2000. Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage responses. Nature 406:210–215.
   PubMed Web of Science ®Google Scholar
• Lim, D. S., S. T. Kim, B. Xu, R. S. Maser, J. Lin, J. H. Petrini, and M. B. Kastan. 2000. ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway. Nature 404:613–617.
   PubMed Web of Science ®Google Scholar
• Martin, A., and B. Weber. 2000. Genetic and hormonal risk factors in breast cancer. J. Natl. Cancer Inst. 92:1126–1135.
   PubMed Web of Science ®Google Scholar
• Matsuoka, S., G. Rotman, A. Ogawa, Y. Shiloh, K. Tamai, and S. Elledge. 2000. Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro. Proc. Natl. Acad. Sci. USA 97:10389–10394.
   PubMed Web of Science ®Google Scholar
• Morgan, S. E., and M. B. Kastan. 1997. p53 and ATM: cell cycle, cell death, and cancer. Adv. Cancer Res. 71:1–25.
   PubMed Web of Science ®Google Scholar
• Morgan, S. E., C. Lovly, T. K. Pandita, Y. Shiloh, and M. B. Kastan. 1997. Fragments of ATM which have dominant-negative or complementing activity. Mol. Cell. Biol. 17:2020–2029.
   PubMed Web of Science ®Google Scholar
• Painter, R. B., and B. R. Young. 1980. Radiosensitivity in ataxia-telangiectasia: a new explanation. Proc. Natl. Acad. Sci. USA 77:7315–7317.
   PubMed Web of Science ®Google Scholar
• Rotman, G., and Y. Shiloh. 1999. ATM: a mediator of multiple responses to genotoxic stress. Oncogene 18:6135–6144.
   PubMedGoogle Scholar
• Scully, R., and D. Livingston. 2000. In search of the tumour-suppressor functions of BRCA1 and BRCA2. Nature 408:429–432.
   PubMed Web of Science ®Google Scholar
• Scully, R., G. Shridar, K. Vlasakova, J. Chen, M. Socolovsky, and D. Livingston. 1999. Genetic analysis of BRCA1 function in a defined tumor cell line. Mol. Cell 4:1093–1099.
   PubMed Web of Science ®Google Scholar
• Shiloh, Y.. 1997. Ataxia-telangiectasia and the Nijmegen breakage syndrome: related disorders but genes apart. Annu. Rev. Genet. 31:635–662.
   PubMed Web of Science ®Google Scholar
• Siliciano, J. D., C. E. Canman, Y. Taya, K. Sakaguchi, E. Appella, and M. B. Kastan. 1997. DNA damage induces phosphorylation of the amino terminus of p53. Genes Dev. 11:3471–3481.
   PubMed Web of Science ®Google Scholar
• Tibbetts, R., D. Cortez, K. Brumbaugh, R. Scully, D. Livingston, S. Elledge, and R. Abraham. 2000. Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress. Genes Dev. 14:2989–3002.
   PubMed Web of Science ®Google Scholar
• Xu, X., Z. Weaver, S. P. Linke, C. Li, J. Gotay, X. W. Wang, C. C. Harris, T. Ried, and C. X. Deng. 1999. Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells. Mol. Cell 3:389–395.
   PubMed Web of Science ®Google Scholar
• Zampetti-Bosseler, F., and D. Scott. 1981. Cell death, chromosome damage and mitotic delay in normal human, ataxia telangiectasia and retinoblastoma fibroblasts after X-irradiation. Int. J. Radiat. Biol. 39:547–558.
   Web of Science ®Google Scholar
• Zhao, S., Y. C. Weng, S. S. Yuan, Y. T. Lin, H. C. Hsu, S. C. Lin, E. Gerbino, M. H. Song, M. Z. Zdzienicka, R. A. Gatti, J. W. Shay, Y. Ziv, Y. Shiloh, and E. Y. Lee. 2000. Functional link between ataxia-telangiectasia and Nijmegen breakage syndrome gene products. Nature 405:473–477.
   PubMed Web of Science ®Google Scholar
• Ziv, Y., A. Bar-Shira, I. Pecker, P. Russell, T. J. Jorgensen, I. Tsarfati, and Y. Shiloh. 1997. Recombinant ATM protein complements the cellular A-T phenotype. Oncogene 15:159–167.
   PubMed Web of Science ®Google Scholar